- Home
- NCRA vs AIMD Comparison
NCRA vs AIMD Comparison
Compare NCRA & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- AIMD
- Stock Information
- Founded
- NCRA 2002
- AIMD 1984
- Country
- NCRA Taiwan
- AIMD United States
- Employees
- NCRA N/A
- AIMD N/A
- Industry
- NCRA Farming/Seeds/Milling
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- AIMD Health Care
- Exchange
- NCRA Nasdaq
- AIMD Nasdaq
- Market Cap
- NCRA 16.1M
- AIMD 16.9M
- IPO Year
- NCRA N/A
- AIMD N/A
- Fundamental
- Price
- NCRA $1.01
- AIMD $1.81
- Analyst Decision
- NCRA
- AIMD
- Analyst Count
- NCRA 0
- AIMD 0
- Target Price
- NCRA N/A
- AIMD N/A
- AVG Volume (30 Days)
- NCRA 1.9M
- AIMD 43.3K
- Earning Date
- NCRA 11-14-2025
- AIMD 11-13-2025
- Dividend Yield
- NCRA N/A
- AIMD N/A
- EPS Growth
- NCRA N/A
- AIMD N/A
- EPS
- NCRA N/A
- AIMD N/A
- Revenue
- NCRA $14,106,275.00
- AIMD $113,037.00
- Revenue This Year
- NCRA N/A
- AIMD N/A
- Revenue Next Year
- NCRA N/A
- AIMD N/A
- P/E Ratio
- NCRA N/A
- AIMD N/A
- Revenue Growth
- NCRA N/A
- AIMD 178.19
- 52 Week Low
- NCRA $0.70
- AIMD $1.84
- 52 Week High
- NCRA $2.40
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- NCRA 34.29
- AIMD 25.02
- Support Level
- NCRA $0.94
- AIMD $1.89
- Resistance Level
- NCRA $1.14
- AIMD $2.28
- Average True Range (ATR)
- NCRA 0.12
- AIMD 0.22
- MACD
- NCRA -0.02
- AIMD -0.09
- Stochastic Oscillator
- NCRA 17.74
- AIMD 6.03
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.